A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients. Martinez Sanchez MP, Megias-Vericat JE, Rodriguez-Veiga R, Vives S, et al. Ann Hematol 2021 Apr 29. pii: 10.1007/s00277-021-04542.

Read + Share

Amedeo Smart

Independent Medical Education

Martinez Sanchez MP, Megias-Vericat JE, Rodriguez-Veiga R, Vives S, et al. A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients. Ann Hematol 2021 Apr 29. pii: 10.1007/s00277-021-04542.
PMID: 33914097